11
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T82194 |
HIV-IN-9
|
||
HIV-IN-9 (Compound 2b)为一种HIV抑制剂,IC50值为6.65 μg/mL,对HIV-RT展现出高度结合亲和力。此外,HIV-IN-9亦能抑制CYP3A4、CYP1A2、CYP2C1和CYP2D6等多种酶。 | |||
T79295 | HIV-1 protease-IN-9 | HIV Protease | Microbiology/Virology; Proteases/Proteasome |
HIV-1protease-IN-9 (compound 5b)为HIV-1蛋白酶抑制剂,具有0.028 nM的Ki值和66.8 nM的IC50,表现出显著的抗病毒活性。 | |||
TQ0174 |
Mavorixafor
AMD-070 |
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
Mavorixafor (AMD-070) 是一种有效的特异性 CXCR4 拮抗剂,对 CXCR4 125I-SDF 结合的 IC50 值为 13 nM。 Mavorixafor 在 MT-4 细胞 (IC50 = 1 nM) 和 PBMC (IC50 = 9 nM) 中抑制 T-tropic HIV-1 (NL4.3 株) 的复制。 | |||
T10296 |
Mavorixafor trihydrochloride
AMD-070 trihydrochloride |
HIV Protease | Microbiology/Virology; Proteases/Proteasome |
Mavorixafor trihydrochloride is a selective and orally available CXCR4 antagonist (IC50: 13 nM against CXCR4 125I-SDF binding) and also inhibits the replication of T-tropic HIV-1 (NL4.3 strain) in MT-4 cells and PBMCs (IC50s: 1 and 9 nM). | |||
T79974 |
HIV-IN-8
|
||
HIV-IN-8(Compound 9)为抗HIV药物,通过抑制HIV复制发挥作用,其半抑制浓度(EC50)为13 μg/mL。 | |||
T61797 |
HIV-1 inhibitor-15
|
||
HIV-1 inhibitor-15 (compound 9d) is a potent and broad-spectrum inhibitor targeting HIV-1. It exhibits inhibitory activity against HIV-1 WT, L100I, K103N, Y181C, and E138K with respective EC50 values of 1.7 nM, 4 nM, 2 nM, 6 nM, and 9 nM. In addition to its high efficacy, HIV-1 inhibitor-15 possesses favorable solubility, safety profiles, and oral bioavailability [1]. | |||
T81037 |
Tat-HA-NR2B9c
|
||
Tat-HA-NR2B9 是一种包括HIV-1 Tat细胞膜转导结构域片段、流感病毒血凝素(HA)表位标签以及NR2B(NR2B9c) C端9个氨基酸的化学复合物。该化合物能够降低大鼠缺血性脑损伤的梗塞面积,同时促进神经功能的恢复。 | |||
T37713 |
Funalenone
|
||
Funalenone is a phenalenone originally isolated from A. niger. It inhibits HIV-1 integrase (IC50 = 10 μM) and HIV-1 replication in human peripheral blood cells transformed by murine leukemia virus (HPB-M(a); IC50 = 1.7 μM) but is less cytotoxic to mammalian HPB-M(a) cells (IC50 = 87 μM). Funalenone selectively inhibits matrix metalloproteinase-1 (MMP-1; IC50 = 170 μM) over MMP-2 and MMP-9, which it inhibits by 18.3 and 38.2%, respectively, when used at a concentration of 400 μM. It also inhibits... | |||
T37344 |
5,6-dimethyl-2-Thiouracil
|
||
5,6-dimethyl-2-Thiouracil is a heterocyclic building block that has been used in the synthesis of anti-HIV-1 pyrimidinones.1 It has also been used as an internal standard for the quantification of thyreostats, including 2-thiouracil, in bovine plasma.2 |1. Navrotskii, M.B. Synthesis and anti-HIV-1 activity of new 2-[(2-phthalimidoethyl)thio]-4(3H)-pyrimidinone derivatives. Pharm. Chem. J. 39(9), 466-467 (2005).|2. Schmidt, K.S. In-house validation and factorial effect analysis of a liquid chroma... | |||
T35762 | MC1742 | ||
MC1742 is an inhibitor of class I histone deacetylases (HDACs; IC50s = 0.1, 0.11, 0.02, and 0.61 μM for HDAC1, -2, -3, and -8, respectively) and class IIb HDACs (IC50s = 7 and 40 nM for HDAC6 and HDAC10, respectively).1 It is selective for class I and class IIb over class IIa HDACs (IC50s = >50 μM for HDAC4, -5, -7, and -9). MC1742 reduces proliferation of HOS, MG-63, RD, A204, SK-ES-1, and A673 sarcoma cancer stem cells (CSCs). It increases levels of acetylated histone H3 and acetylated tubulin... | |||
T37347 |
6'-Sialyllactose Sodium Salt
6'-Sialyllactose Sodium Salt,6'-N-Acetylneuraminyl-D-lactose |
||
6'-Sialyllactose consists of the monosaccharide N-acetylneuraminic acid linked to the galactosyl subunit of lactose at the 6 position. This connection is at the 3 position in the related compound, 3’-sialyllactose. Both are major milk oligosaccharides that avidly bind several viral strains, including strains of influenza, HIV-1, reovirus, and polyomavirus.[1],[2],[3],[4],[5],[6] These compounds can be used to differentiate and characterize the binding domains of viruses that recognize N-acetylne... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T36438 |
Sporogen-AO 1
|
||
Sporogen-AO 1 is a fungal metabolite originally isolated fromA. oryzaethat has diverse biological activities.1,2,3,4,5It inhibits HIV-1 Tat transactivation in a cell-based assay with an IC50value of 15.8 μM.4Sporogen-AO 1 is cytotoxic to HeLa, KB, and NCI H187 cancer cells (IC50s = 8.3, 9, and 5.1 μM, respectively).2,5It is active againstC. albicans(MIC = 4 mM).3 1.Tanaka, S., Wada, K., Marumo, S., et al.Structure of sporogen-ao 1, a sporogenic substance of Aspergillus oryzaeTetrahedron Lett.25(... |